Position in AMGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,684,746
+$5,845 QoQ
Shares Held
12,937
-2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#874
of 3,140 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2025CallValue
$3,182,994
CallShares
11,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Revolve Wealth Partners, LLC holds $14,063,282 across 9 Drug Manufacturers - General names. AMGN ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
12,937 | $4,684,746 | |
| 2 | JNJ |
Johnson & Johnson
|
12,023 | $3,053,481 | |
| 3 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 4 | ABBV |
AbbVie Inc.
|
7,998 | $2,012,616 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,669 | $728,466 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,473 | $691,458 | |
| 7 | PFE |
Pfizer Inc
|
12,536 | $301,866 | |
| 8 | AZN |
Astrazeneca PLC
|
1,337 | $253,521 |
All Filings in AMGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,684,746 | 12,937 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $4,678,901 | 13,298 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,553,209 | 13,911 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $4,080,894 | 14,461 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $4,223,609 | 15,127 | Shares | Sole | 2025-07-28 | |
| 2025-06-30 | $3,182,994 | 11,400 | Call | Sole | 2025-07-28 | |
| 2025-03-31 | $4,828,090 | 15,497 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,254,426 | 16,323 | Shares | Sole | 2025-03-19 | |
| 2024-09-30 | $5,372,207 | 16,673 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $5,295,402 | 16,948 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $4,935,510 | 17,359 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $5,026,813 | 17,453 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $4,690,130 | 17,451 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,837,837 | 17,286 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,168,011 | 17,241 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $4,559,955 | 17,362 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $4,277,641 | 18,978 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,600,559 | 18,909 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $4,554,679 | 18,835 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $6,417,044 | 28,524 | Shares | Sole | 2022-02-04 | |
| No filing history on record for this holder in this stock. | ||||||